Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
Portfolio
Curis
Develops innovative therapeutics targeting cancer network disruption
Lexington, MA
NASDAQ: CRIS
Contact:
Marty Sutter
Formerly Known As: Reprogenesis
Acquisition
Acquired by: Taseko
Exit date: September 08, 2014